Lin H Y, Shyur S D, Fu J L, Lai Y C
Department of Pediatrics and Medical Research, Mackay Memorial Hospital, Taipei, Taiwan, R.O.C.
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1998 Mar-Apr;39(2):99-102.
We studied 30 atopic children who suspected of milk allergy by past history (age ranging from 1 yr 4 mo to 9 yr 6 mo, mean age: 5.03 yr.) diagnosed as having asthma, atopic dermatitis and/or allergic rhinitis. These 30 atopic children had been screened from the patients at our outpatient clinic by the Pharmacia CAP system RAST FEIA. All of them showed the presence of at least Class II (greater than 0.7 ku/l) IgE specific to proteins in cow's milk. Further analysis found IgE specific to alpha-lactoalbumin (alpha-LA) elevated in 1 patient (3.3%), 1 patient (3.3%) to beta-lactoglobulin (beta-LG), 4 patients (13.3%) to alpha-LA and beta-LG, 5 patients (16.7%) to casein, 8 patients (26.7%) to casein and alpha-LA, 11 patients (36.7%) to casein, alpha-LA and beta-LG. After 3 weeks' cow-milk-free diet, the patient's milk challenge test was performed at our outpatient clinic. According to the test result, none of these 30 atopic children showed clinical evidence of significant allergic reaction to cow's milk in the skin, the gastrointestinal tract or the respiratory tract either within two hours after the challenge test or within 3 days after they went home. We therefore conclude that: (1) No single major allergen is apparent in cow's milk: casein, alpha-LA and beta-LG all show a high proportion of positive reaction. (2) Many atopic children fully tolerate cow's milk, although they have high titer of IgE antibodies specific to cow's milk. The RAST test is only the first step to screen patients with suspected IgE-mediated allergies. To make sure, any positive reaction must be confirmed by the "golden standard" for diagnosis, i.e., the double-blind placebo-controlled food challenge.
我们研究了30名有特应性的儿童,这些儿童根据既往病史怀疑对牛奶过敏(年龄范围为1岁4个月至9岁6个月,平均年龄:5.03岁),被诊断患有哮喘、特应性皮炎和/或过敏性鼻炎。这30名有特应性的儿童是通过Pharmacia CAP系统RAST FEIA从我们门诊的患者中筛选出来的。他们所有人都显示存在至少II类(大于0.7 ku/l)针对牛奶中蛋白质的特异性IgE。进一步分析发现,1名患者(3.3%)的α-乳白蛋白(α-LA)特异性IgE升高,1名患者(3.3%)对β-乳球蛋白(β-LG)特异性IgE升高,4名患者(13.3%)对α-LA和β-LG特异性IgE升高,5名患者(16.7%)对酪蛋白特异性IgE升高,8名患者(26.7%)对酪蛋白和α-LA特异性IgE升高,11名患者(36.7%)对酪蛋白、α-LA和β-LG特异性IgE升高。经过3周无牛奶饮食后,在我们门诊对患者进行了牛奶激发试验。根据试验结果,这30名有特应性的儿童在激发试验后两小时内或回家后3天内,均未在皮肤、胃肠道或呼吸道表现出对牛奶有明显过敏反应的临床证据。因此我们得出结论:(1)牛奶中没有单一的主要过敏原:酪蛋白、α-LA和β-LG均显示出较高比例的阳性反应。(2)许多有特应性的儿童尽管对牛奶有高滴度的特异性IgE抗体,但仍能完全耐受牛奶。RAST试验只是筛查疑似IgE介导过敏患者的第一步。为了确定,任何阳性反应都必须通过诊断的“金标准”,即双盲安慰剂对照食物激发试验来证实。